Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome
Abstract
BACKGROUND & AIMS: Only a fraction of patients with irritable bowel syndrome (IBS) show hypersensitivity to rectal distention. The current study sought to determine if repetitive high-pressure stimulation of sigmoid mechanoreceptors modulates perception of rectal pain and discomfort. METHODS: In 14 patients with IBS and 11 healthy controls, perception thresholds for discomfort and pain during rectal sensory tracking and verbal descriptor ratings of the perceived intensity of a rectal tonic stimulus were obtained before and after repetitive high- pressure mechanical sigmoid stimulation. Gastrointestinal and psychological symptoms were assessed by questionnaires. RESULTS: Despite heterogeneity in baseline rectal sensitivity in patients with IBS, after sigmoid stimulation, 100% of patients, regardless of baseline sensitivity, developed rectal hyperalgesia manifested by at least two of the following three criteria: lowered thresholds for pain and discomfort and increased viscerosomatic referral and lower abdominal discomfort outlasting the experimental stimulation. This pattern of responses was not observed in any of the healthy controls. CONCLUSIONS: In patients with IBS, repetitive stimulation of sigmoid splanchnic afferents results in the development of central sensitization manifested as hyperalgesia and increased viscerosomatic referral during rectal distention and as spontaneous rectosigmoid hyperalgesia in the absence of applied stimuli. Repetitive sigmoid contractions may induce rectosigmoid hyperalgesia in patients with IBS. (Gastroenterology 1997 Jan;112(1):55-63)
References (0)
Cited by (346)
Abdominal pain and cyclic vomiting
2022, Primer on the Autonomic Nervous System, Fourth EditionRising interest in the “brain–gut connection” originates from recent developments in functional gastrointestinal disorders (FGIDs). These highly prevalent disorders clearly involve both the autonomic and enteric nervous systems, yet the role of each in disease and symptom production remains unknown. FGIDs are evolving into a model for the study of the brain–gut connection, which is clearly bidirectional. The current bio-psychosocial conceptualization of FGIDs best describes the multiple factors involved in their pathogenesis. In a simplistic way, the brain–gut connection can be viewed as the central nervous system (brain) and the enteric nervous system (gut) being connected through both an afferent sensory system and an efferent system, the autonomic nervous system. Therefore, this model requires an understanding of factors pertaining to all three of these entities.
Mechano-Regulation of Gene Expression in the Gut: Implications in Pathophysiology and Therapeutic Approaches in Obstructive, Inflammatory, and Functional Bowel Disorders
2022, Comprehensive PharmacologyThe gastrointestinal (GI) tract is composed of a series of hollow organs, subject to transient or persistent mechanical stress. Recent studies have revealed that persistent mechanical stress is present in obstructive and inflammatory conditions and alters gene transcription in the GI tract. Mechanical stress-induced gene expression (mechano-transcription) of inflammatory molecules, pain mediators, pro-fibrotic and growth factors has been shown to play a critical role in pathogenesis of motility dysfunction, visceral hypersensitivity, inflammation, and fibrosis in the gut. Specifically, mechanical stress-induced cyclo-oxygenase-2 (COX-2) and other pro-inflammatory mediators in gut smooth muscle cells account for motility dysfunction and inflammatory process. Mechano-transcription of nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and other pain mediators may lead to visceral hypersensitivity. Emerging evidence suggests that mechanical stress in the gut also leads to up-regulation of certain pro-fibrotic and proliferative mediators such as connective tissue growth factor (CTGF) and osteopontin (OPN), which may contribute to fibrostenotic Crohn’s disease. In this chapter, we will discuss the pathophysiological significance of mechano-transcription of pro-inflammatory molecules, pain mediators, pro-fibrotic and growth factors in obstructive, inflammatory, and functional bowel disorders. We will also evaluate potential therapeutic targets of mechano-transcription process for the management of these disorders.
The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p, and MicroRNA-338-3p Are Downregulated in Irritable Bowel Syndrome and Are Associated With Barrier Function and MAPK Signaling
2021, GastroenterologyAlterations in microRNA (miRNA) and in the intestinal barrier are putative risk factors for irritable bowel syndrome (IBS). We aimed to identify differentially expressed colonic mucosal miRNAs, their targets in IBS compared to healthy controls (HCs), and putative downstream pathways.
Twenty-nine IBS patients (15 IBS with constipation [IBS-C], 14 IBS with diarrhea [IBS-D]), and 15 age-matched HCs underwent sigmoidoscopy with biopsies. A nCounter array was used to assess biopsy specimen-associated miRNA levels. A false discovery rate (FDR) < 10% was considered significant. Real-time polymerase chain reaction (PCR) was used to validate differentially expressed genes. To assess barrier function, trans-epithelial electrical resistance (TEER) and dextran flux assays were performed on Caco-2 intestinal epithelial cells that were transfected with miRNA-inhibitors or control inhibitors. Protein expression of barrier function associated genes was confirmed using western blots.
Four out of 247 miRNAs tested were differentially expressed in IBS compared to HCs (FDR < 10%). Real-time PCR validation suggested decreased levels of miR-219a-5p and miR-338-3p in IBS (P = .026 and P = .004), and IBS-C (P = .02 and P = .06) vs. HCs as the strongest associations. Inhibition of miR-219a-5p resulted in altered expression of proteasome/barrier function genes. Functionally, miR-219a-5p inhibition enhanced the permeability of intestinal epithelial cells as TEER was reduced (25-50%, P < .05) and dextran flux was increased (P < .01). Additionally, inhibition of miR-338-3p in cells caused alterations in the mitogen-activated protein kinase (MAPK) signaling pathway genes.
Two microRNAs that potentially affect permeability and visceral nociception were identified to be altered in IBS patients. MiR-219a-5p and miR-338-3p potentially alter barrier function and visceral hypersensitivity via neuronal and MAPK signaling and could be therapeutic targets in IBS.
Neuropathophysiology of the Irritable Bowel Syndrome
2018, Physiology of the Gastrointestinal Tract, Sixth EditionThe irritable bowel syndrome (IBS) may well reflect a neurological problem emerging from disordered neurophysiology in the enteric nervous system (ENS), the central nervous system (CNS), or in both simultaneously. A normally functioning ENS is essential for a symptom-free gut: the gut does not work at all when the ENS is absent (e.g., Hirschsprung’s disease). This chapter deals mainly with enteric neuroimmune pathophysiology to the exclusion of multiple other explanations, hypotheses and theories, such as small intestinal bacterial overgrowth, gas generating foods, fructose malabsorption, maladjustment to life circumstances, among others that speak to IBS.
Concepts for the neuropathophysiology of the hallmark symptoms of IBS, which include abdominal pain, defecation urgency, bloating, and alterations in stool consistency, emerge in this chapter. Emphasis is focused on gaining acquaintance with the neurophysiology of visceral pain, ENS control of intestinal motility, and ENS control of mucosal secretion as a requirement for productive basic and translational interpretation of the hallmark symptoms.
Mastocytotic enteritis is explored as a biomarker in the context of the diarrhea-predominant form of IBS. This involves release by enteric mast cells of multiple inflammatory mediators that act in paracrine signaling manner at receptors expressed by ENS neurons and intramural sensory afferent terminals. Afferent sensitization amplifies nociceptive input to the CNS and becomes a factor in IBS-related pain.
Enteric mast cells use immunological memory to detect specific foreign antigens as they appear and reappear inside the gut lumen throughout the lifetime of an individual. Paracrine signaling relays the information on foreign antigen identity to the ENS. Paracrine signals, coming from mast cells, are interpreted in turn by the ENS as a labeled code for the presence of an antigenic threat in the intestinal lumen. The ENS interprets the signal as a potential threat to homeostatic integrity and “calls up,” from its program library, secretory and propulsive motor behavior organized for rapid and effectively expulsion of the menace. Commonalty of symptoms between postinfectious IBS and acute psychogenic stress in IBS are likely reflections of neuroimmune communication that includes degranulation of enteric mast cells.
Autoimmune-related enteric neuropathy underlies symptoms in disorders that include lower esophageal sphincter achalasia, intestinal pseudoobstruction, small-cell carcinoma in the lungs, and IBS. Functional symptoms in a subset of IBS patients reflect enteric neuronal damage or ablation related to circulating antienteric autoimmune antibodies.
Menthacarin treatment attenuates nociception in models of visceral hypersensitivity
2024, Neurogastroenterology and MotilityComorbid extra-intestinal central sensitization conditions worsen irritable bowel syndrome in primary care patients
2023, Neurogastroenterology and Motility